Table 2: Time between fulfillment of Notice of Compliance with conditions and publication of confirmatory study*
DrugTime, d
Between publication and NOC/c fulfillmentBetween NOC/c fulfillment and publication
Abacavir87, 187, 238
Alteplase1260104
Anastrozole14311311
Aztreonam487
Bortezomib817
Capecitabine1048
Darunavir585124
Dasatinib1024210
Delavirdine979
Exemestane4791335, 1364
Gefitinib212, 391, 1511
Imatinib58, 184, 380, 424, 689, 912655, 708
Lenalidomide280
Letrozole1041160, 308
Levodopa/carbidopa82339
Nilotinib19, 269
Pregabalin320
Raltegravir223
Recombinant factor VIIa813
Sorafenib28, 405
Sunitinib265, 1198, 1416
Tenofovir371, 687
Zanamivir1198
Overall mean (95% CI)610 (439-780)572 (338-805)

Note: CI = confidence interval, NOC/c = Notice of Compliance with conditions.

*Riluzole omitted from table because no publication found.